Table II.
Risk score | Wald χ2 | Sub-distribution hazard ratio* (95% CI) | P | C-statistic (95% CI) | Calibration HL χ2† |
---|---|---|---|---|---|
Primary analysis, n observations = 9722 | |||||
CHARGE-AF | 403 | 2.15 (1.99, 2.31) | <.0001 | 0.757 (0.741, 0.762) | 5.6 (P = .69) |
CHA2DS2-VASc | 209 | 1.43 (1.37, 1.51) | <.0001 | 0.712 (0.693, 0.731) | 28.5 (P < .0001) |
CHA2DS2-VASc lone AF women | 288 | 1.45 (1.39, 1.51) | <.0001 | 0.730 (0.713, 0.747) | 35.5 (P < .0001) |
CHA2DS2-VASc no sex | 360 | 1.56 (1.49,1.63) | <.0001 | 0.741 (0.724, 0.758) | 28.5 (P < .0001) |
Sensitivity analysis, n observations = 4797 | |||||
CHARGE-AF | 208 | 1.90 (1.74, 2.07) | <.0001 | 0.713 (0.693, 0.733) | 12.7 (P = .12) |
CHA2DS2-VASc | 89 | 1.34 (1.26, 1.42) | <.0001 | 0.673 (0.652, 0.695) | 12.67 (P = .03) |
CHA2DS2-VASc lone AF women | 125 | 1.36 (1.29, 1.43) | <.0001 | 0.684 (0.663, 0.705) | 19.8 (P = .001) |
CHA2DS2-VASc no sex | 173 | 1.46 (1.38, 1.54) | <.0001 | 0.699 (0.678, 0.720) | 10.6 (0.06) |
Sub-distribution hazard ratios are per unit change in respective scores. HL, Hosmer-Lemeshow.